![](https://cdn.sanity.io/images/0vv8moc6/hcplive/122a645324b75036ea52d93be5255a8562d13766-880x876.png?fit=crop&auto=format)
Biosimilars Month in Review: July 2024
The biosimilars month in review highlights the US Food and Drug Administration (FDA) approvals of biosimilars for the treatment of rare diseases, ophthalmologic conditions, and rheumatic diseases. New data emphasize biosimilars' clinical equivalence to …